10,178 Procter & Gamble Company (The) $PG Shares Acquired by Signaturefd LLC

Signaturefd LLC increased its holdings in Procter & Gamble Company (The) (NYSE:PG) by 14.4% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 80,702 shares of the company’s stock after buying an additional 10,178 shares during the period. Signaturefd LLC’s holdings in Procter & Gamble were worth $11,724,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Bond & Devick Financial Network Inc. lifted its holdings in shares of Procter & Gamble by 5.3% in the third quarter. Bond & Devick Financial Network Inc. now owns 7,562 shares of the company’s stock valued at $1,099,000 after purchasing an additional 381 shares in the last quarter. McGuire Investment Group LLC grew its position in shares of Procter & Gamble by 9.3% in the third quarter. McGuire Investment Group LLC now owns 2,937 shares of the company’s stock valued at $427,000 after purchasing an additional 250 shares during the last quarter. Simplicity Wealth LLC increased its stake in shares of Procter & Gamble by 3.5% during the 3rd quarter. Simplicity Wealth LLC now owns 66,516 shares of the company’s stock worth $9,664,000 after purchasing an additional 2,224 shares in the last quarter. Brookmont Capital Management increased its stake in shares of Procter & Gamble by 34.4% during the 3rd quarter. Brookmont Capital Management now owns 32,483 shares of the company’s stock worth $4,719,000 after purchasing an additional 8,309 shares in the last quarter. Finally, NTV Asset Management LLC increased its stake in shares of Procter & Gamble by 28.5% during the 3rd quarter. NTV Asset Management LLC now owns 39,756 shares of the company’s stock worth $5,776,000 after purchasing an additional 8,824 shares in the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble News Summary

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Multiple analysts raised targets and maintained bullish ratings. UBS lifted its target to $190 and retained a Buy rating, while Citigroup raised its target to $187, BNP Paribas Exane to $189, and JPMorgan to $180. Freedom Broker also upgraded PG from Hold to Buy with a $176 target. These revisions suggest analysts believe the earnings improvement and resilient demand can support further gains.
• Positive Sentiment: Fiscal Q1 results exceeded expectations. Adjusted EPS was $2.00 versus the $1.89 consensus, while revenue increased 4% year over year to $23.28 billion, topping estimates of approximately $22.80 billion. Organic sales also grew 4%, with volume contributing 2.4 percentage points. Procter & Gamble earnings beat as sales rise 4%
• Positive Sentiment: Demand and operating trends remain encouraging. Stronger volumes, favorable product mix, productivity savings, and resilient laundry and home-product sales supported the quarter. Investors also continue to value PG’s defensive business mix and 70-year record of dividend increases. P&G dividend history
• Neutral Sentiment: Fiscal 2027 guidance was mixed. The company raised its all-in sales-growth outlook, partly reflecting the Thorne acquisition, but projected revenue of $86.0 billion to $87.7 billion remains below the roughly $88.8 billion consensus. EPS guidance of $6.89 to $7.11 brackets expectations of $6.98.
• Negative Sentiment: Commodity and energy inflation remain the main risks. Higher oil, raw-material, transportation, and energy costs are expected to create an estimated $1.4 billion headwind and pressure margins. TD Cowen raised its target to $166 but kept a Hold rating, warning that cost inflation could limit the recovery. P&G commodity cost outlook

Insider Activity

In other Procter & Gamble news, insider Susan Whaley sold 2,369 shares of Procter & Gamble stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $145.34, for a total value of $344,310.46. Following the completion of the sale, the insider directly owned 30,730 shares of the company’s stock, valued at approximately $4,466,298.20. The trade was a 7.16% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Marc Pritchard sold 4,030 shares of the business’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $143.79, for a total value of $579,473.70. Following the completion of the transaction, the insider owned 187,001 shares of the company’s stock, valued at $26,888,873.79. This trade represents a 2.11% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 15,135 shares of company stock valued at $2,189,970 in the last 90 days. Insiders own 0.23% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on PG. Evercore upgraded Procter & Gamble from an “in-line” rating to an “outperform” rating and set a $166.00 price objective for the company in a research report on Tuesday, October 6th. HSBC reiterated a “hold” rating and set a $149.00 target price (down from $182.00) on shares of Procter & Gamble in a report on Thursday, July 30th. Sanford C. Bernstein reissued a “market perform” rating and set a $149.00 price target on shares of Procter & Gamble in a research report on Monday, August 24th. Weiss Ratings reissued a “hold (c)” rating on shares of Procter & Gamble in a research report on Monday, September 21st. Finally, UBS Group set a $166.00 price target on Procter & Gamble in a report on Friday. Fifteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. Based on data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus price target of $168.90.

Procter & Gamble Price Performance

NYSE:PG opened at $161.21 on Friday. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $167.25. The firm has a market cap of $374.43 billion, a price-to-earnings ratio of 24.28, a price-to-earnings-growth ratio of 4.00 and a beta of 0.39. The company’s 50-day moving average is $148.41 and its two-hundred day moving average is $147.09. The company has a current ratio of 0.72, a quick ratio of 0.47 and a debt-to-equity ratio of 0.40.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, topping analysts’ consensus estimates of $1.89 by $0.11. The business had revenue of $23.28 billion during the quarter, compared to the consensus estimate of $22.80 billion. Procter & Gamble had a net margin of 18.23% and a return on equity of 30.91%. The company’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.99 earnings per share. Research analysts expect that Procter & Gamble Company will post 6.98 EPS for the current year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be given a dividend of $1.0885 per share. The ex-dividend date is Friday, October 23rd. This represents a $4.35 dividend on an annualized basis and a yield of 2.7%. Procter & Gamble’s dividend payout ratio (DPR) is 65.51%.

About Procter & Gamble

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.